» Articles » PMID: 10777787

Brain-derived Neurotrophic Factor Differentially Regulates Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures

Overview
Journal J Neurosci
Specialty Neurology
Date 2000 Apr 25
PMID 10777787
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Brain-derived neurotrophic factor (BDNF) has been postulated to be a key signaling molecule in regulating synaptic strength and overall circuit activity. In this context, we have found that BDNF dramatically increases the frequency of spontaneously initiated action potentials in hippocampal neurons in dissociated culture. Using analysis of unitary synaptic transmission and immunocytochemical methods, we determined that chronic treatment with BDNF potentiates both excitatory and inhibitory transmission, but that it does so via different mechanisms. BDNF strengthens excitation primarily by augmenting the amplitude of AMPA receptor-mediated miniature EPSCs (mEPSCs) but enhances inhibition by increasing the frequency of mIPSC and increasing the size of GABAergic synaptic terminals. In contrast to observations in other systems, BDNF-mediated increases in AMPA-receptor mediated mEPSC amplitudes did not require activity, because blocking action potentials with tetrodotoxin for the entire duration of BDNF treatment had no effect on the magnitude of this enhancement. These forms of synaptic regulations appear to be a selective action of BDNF because intrinsic excitability, synapse number, and neuronal survival are not affected in these cultures. Thus, although BDNF induces a net increase in overall circuit activity, this results from potentiation of both excitatory and inhibitory synaptic drive through distinct and selective physiological mechanisms.

Citing Articles

Implications of Aperiodic and Periodic EEG Components in Classification of Major Depressive Disorder from Source and Electrode Perspectives.

Zandbagleh A, Sanei S, Azami H Sensors (Basel). 2024; 24(18).

PMID: 39338848 PMC: 11436117. DOI: 10.3390/s24186103.


Time-dependent homeostatic mechanisms underlie brain-derived neurotrophic factor action on neural circuitry.

ONeill K, Anderson E, Mukherjee S, Gandu S, McEwan S, Omelchenko A Commun Biol. 2023; 6(1):1278.

PMID: 38110605 PMC: 10728104. DOI: 10.1038/s42003-023-05638-9.


Retinoic acid-gated BDNF synthesis in neuronal dendrites drives presynaptic homeostatic plasticity.

Thapliyal S, Arendt K, Lau A, Chen L Elife. 2022; 11.

PMID: 36515276 PMC: 9797192. DOI: 10.7554/eLife.79863.


BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders.

Bazzari A, Bazzari F Int J Mol Sci. 2022; 23(15).

PMID: 35955546 PMC: 9368938. DOI: 10.3390/ijms23158417.


Brain-Derived Neurotropic Factor in Neurodegenerative Disorders.

Ibrahim A, Chauhan L, Bhardwaj A, Sharma A, Fayaz F, Kumar B Biomedicines. 2022; 10(5).

PMID: 35625880 PMC: 9138678. DOI: 10.3390/biomedicines10051143.


References
1.
TAN S, Wenthold R, Soderling T . Phosphorylation of AMPA-type glutamate receptors by calcium/calmodulin-dependent protein kinase II and protein kinase C in cultured hippocampal neurons. J Neurosci. 1994; 14(3 Pt 1):1123-9. PMC: 6577568. View

2.
Nawa H, Carnahan J, Gall C . BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. Eur J Neurosci. 1995; 7(7):1527-35. DOI: 10.1111/j.1460-9568.1995.tb01148.x. View

3.
Conti F, Minelli A, Brecha N . Cellular localization and laminar distribution of AMPA glutamate receptor subunits mRNAs and proteins in the rat cerebral cortex. J Comp Neurol. 1994; 350(2):241-59. DOI: 10.1002/cne.903500208. View

4.
Kang H, Schuman E . Neurotrophin-induced modulation of synaptic transmission in the adult hippocampus. J Physiol Paris. 1995; 89(1):11-22. DOI: 10.1016/0928-4257(96)80547-x. View

5.
Mennerick S, Shen W, Xu W, Benz A, Tanaka K, Shimamoto K . Substrate turnover by transporters curtails synaptic glutamate transients. J Neurosci. 1999; 19(21):9242-51. PMC: 6782901. View